<DOC>
	<DOCNO>NCT01195636</DOCNO>
	<brief_summary>The purpose trial determine XPF-002 safe effective treatment pain subject Postherpetic Neuralgia</brief_summary>
	<brief_title>A Crossover Study Evaluate Safety , Tolerability Efficacy XPF-002 Subjects With Postherpetic Neuralgia ( PHN )</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Age 18 80 year ( inclusive ) ; Males females nonchildbearing potential ( ie , 12 month spontaneous amenorrhea , bilateral oophorectomy least 6 month prior randomization , hysterectomy bilateral oophorectomy least 6 month prior randomization , females 50 year age , hysterectomy without bilateral oophorectomy least 6 month prior randomization ) ; Male subject sexual partner childbearing potential must agree use contraception ( abstinence , birth control pill , ring patch , diaphragm spermicide , intrauterine device , condom vaginal spermicide , surgical sterilization , vasectomy , progestin implant injection ) ; Persistent pain 6 month appearance herpes zoster rash locate face , scalp hairline , proximity mucous membrane ; Diagnosis PHN ; Persistent neuropathic pain involve least 1 dermatome cover 400 cm2 ; Mean daily pain intensity score target area great equal 4 11point Likert NRS minimum 4 day singleblind , placebo runin period ; Subject agrees take protocoldefined rescue medication prescribe ; Intact skin painful area treat ; Able willing provide inform consent comply study procedure . Subject systemic disease would put him/her additional risk limit his/her ability participate study opinion investigator ; Creatinine clearance le 30 mL/min ; Subject know history human immunodeficiency virus , hepatitis C , hepatitis B ; Malignancy basal cell carcinoma carcinoma situ within past 2 year ; Subject history serious mental illness psychiatric illness dementia , depression , schizophrenia , limit his/her ability comply study procedure ; Subject unable apply , care giver apply , study ointment area painful skin segment , BID , within 2 hour wake even dinner ; Subject know sensitivity topical product ; Subject active herpes zoster lesion dermatitis ; Other severe chronic pain may impair selfassessment pain due PHN ; Treatment local anesthetic last 2 week nerve block within last 30 day ; Subject take opioid medication treat his/her PHN pain unable washout medication duration study ; Subject take prohibited medication unable washout treatment duration study ; Subject take 2 permitted concomitant medication treatment PHN unable washout 2 treatment duration study ; Subject take local prescription nonprescription therapy ( lidocaine patch , transcutaneous electrical nerve stimulation , etc . ) unable washout treatment duration study ; Subject use QutenzaÂ® patch 90 day prior screen use capsaicin preparation daily basis 90 day prior screen ; Subject participate 1 topical study pain 3 PHN clinical study ; Pregnant lactating female ; Subject active history alcohol drug abuse ; Subject participate investigational study within 60 day prior screen ; Subject employ Sponsor , study staff , family ; Subject condition would make him/her , opinion investigator Sponsor , unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Pain Shingles , PHN , Postherpetic Neuralgia</keyword>
</DOC>